ROGERS MICHAEL W
Insider CIK 1244159 · ACOR Chief Financial Officer · KERX Director · PSDV Director · BGMD EVP, CFO and Treasurer · ARPO See Remarks · CNDO Director · ARAV Director · AKBA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-06-17 | 2026-06-22 | 35,700 | — | $0 | 197,429 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-11 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-06-10 | 2025-06-11 | 35,700 | — | $0 | 161,729 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-06-06 | 2024-06-10 | 30,000 | — | $0 | 126,029 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 96,029 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-09-23 | 2022-09-26 | 97,063 | — | $0 | 97,063 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-06-08 | 2022-06-09 | 13,700 | — | $0 | 66,029 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2021-09-10 | 2021-09-13 | 22,812 | — | $0 | 22,812 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-06-02 | 2021-06-03 | 13,700 | — | $0 | 52,329 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 15,024 | — | $0 | 15,024 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 14,987 | — | $0 | 14,987 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-06-05 | 2020-06-09 | 13,700 | — | $0 | 38,629 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2019-06-25 | 2019-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-06-21 | 2019-06-24 | 6,667 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-06-21 | 2019-06-24 | 6,667 | — | $0 | 119,167 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 24,929 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2019-05-14 | 2019-05-16 | 169,500 | — | $0 | 169,500 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2019-05-14 | 2019-05-16 | 430,500 | — | $0 | 430,500 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2019-02-15 | 2019-02-20 | 215,328 | — | $0 | 215,328 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer deriv | 2018-12-12 | 2018-12-13 | 140,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 18,716 | — | $0 | 18,716 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer | 2018-12-12 | 2018-12-13 | 30,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2018-11-15 | 2018-11-16 | 100,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2018-11-15 | 2018-11-16 | 100,000 | $1.13 | $113.0K | 112,500 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2018-06-30 | 2018-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2018-06-30 | 2018-07-12 | 10,000 | — | $0 | 30,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2018-06-27 | 2018-06-29 | 12,500 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2018-06-27 | 2018-06-29 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 26,667 | — | $0 | 26,667 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 6,667 | — | $0 | 6,667 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2018-04-23 | 2018-04-25 | 144,000 | — | $0 | 144,000 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2017-12-15 | 2017-12-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2017-12-15 | 2017-12-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2017-12-14 | 2017-12-18 | 293,006 | $5.50 | $1.61M | 0 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2017-06-09 | 2017-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2017-06-09 | 2017-06-20 | 10,000 | — | $0 | 20,000 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2016-12-12 | 2016-12-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2016-05-26 | 2016-05-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2016-05-26 | 2016-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2016-05-11 | 2016-05-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2016-03-02 | 2016-03-04 | 26,796 | — | $0 | 26,796 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2015-12-03 | 2015-12-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2015-12-01 | 2015-12-03 | 964 | $38.06 | $36.7K | 40,713 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2015-10-07 | 2015-10-09 | 1,267 | $29.52 | $37.4K | 46,110 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2015-10-07 | 2015-10-09 | 4,433 | $30.45 | $135.0K | 41,677 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2015-03-04 | 2015-03-06 | 33,278 | — | $0 | 33,278 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award | 2015-03-04 | 2015-03-06 | 5,872 | — | $0 | 47,377 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2014-12-29 | 2014-12-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2014-12-11 | 2014-12-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2014-12-01 | 2014-12-03 | 230 | $35.58 | $8.2K | 41,505 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2014-10-07 | 2014-10-09 | 5,700 | $33.10 | $188.7K | 41,735 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2014-03-05 | 2014-03-07 | 10,396 | — | $0 | 10,396 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award | 2014-03-05 | 2014-03-07 | 1,835 | — | $0 | 47,435 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2013-12-18 | 2013-12-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2013-10-07 | 2013-10-09 | 136,900 | — | $0 | 136,900 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award | 2013-10-07 | 2013-10-09 | 45,600 | — | $0 | 45,600 | SEC↗ |
| CNDO CORONADO BIOSCIENCES INC | A Award deriv | 2013-02-07 | 2013-02-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2012-12-14 | 2012-12-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BGMD BG Medicine, Inc. | A Award deriv | 2012-02-22 | 2012-02-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CNDO CORONADO BIOSCIENCES INC | A Award deriv | 2012-02-10 | 2012-02-14 | 15,000 | — | $0 | 15,000 | SEC↗ |